14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 AMGN stock ended at $299.48. This is 3.79% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.11% from a day low at $297.52 to a day high of $312.73.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Amgen Inc. prices

Date Open High Low Close Volume
Feb 24, 2023 $236.83 $237.06 $233.12 $233.66 1 853 499
Feb 23, 2023 $236.70 $237.86 $234.75 $237.62 2 211 585
Feb 22, 2023 $240.30 $240.99 $235.75 $236.16 2 187 082
Feb 21, 2023 $240.79 $241.92 $238.20 $238.24 2 524 481
Feb 17, 2023 $235.34 $241.72 $233.71 $240.53 2 924 853
Feb 16, 2023 $238.46 $239.01 $234.04 $234.22 3 289 723
Feb 15, 2023 $240.21 $240.54 $238.73 $240.07 1 780 678
Feb 14, 2023 $242.70 $243.00 $239.11 $241.03 2 007 737
Feb 13, 2023 $243.20 $243.83 $241.30 $243.66 2 319 931
Feb 10, 2023 $241.92 $244.14 $240.41 $242.50 2 687 076
Feb 09, 2023 $241.12 $243.46 $238.99 $240.00 3 018 491
Feb 08, 2023 $242.99 $243.56 $239.60 $240.20 2 705 146
Feb 07, 2023 $243.02 $244.94 $241.42 $244.00 2 407 444
Feb 06, 2023 $245.36 $246.80 $243.45 $243.85 2 196 326
Feb 03, 2023 $249.96 $249.96 $242.21 $245.17 3 072 241
Feb 02, 2023 $243.78 $246.57 $236.37 $246.53 5 484 111
Feb 01, 2023 $249.16 $249.55 $240.00 $246.41 5 306 152
Jan 31, 2023 $253.86 $253.86 $249.89 $252.40 3 403 720
Jan 30, 2023 $253.46 $254.16 $250.60 $251.59 2 039 802
Jan 27, 2023 $254.87 $255.50 $252.54 $253.65 2 109 728
Jan 26, 2023 $256.54 $256.69 $253.01 $254.88 2 518 596
Jan 25, 2023 $260.09 $261.55 $256.02 $256.54 1 899 203
Jan 24, 2023 $261.85 $262.00 $257.52 $259.70 1 589 892
Jan 23, 2023 $264.00 $264.73 $259.81 $260.97 2 024 030
Jan 20, 2023 $262.03 $263.84 $259.87 $263.24 2 574 116
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT